I thank my hon. Friend. He is being very generous. Can he not see, though, that supporting the principle of improving access to medical treatments is a completely different kettle of fish from supporting the mechanism whereby an individual Bill attempts to achieve that aim? In other words, it is perfectly consistent to say that one opposes the Bill robustly, as, indeed, did a long list of organisations and people, including research charities, medical royal colleges, Action against Medical Accidents and Sir Robert Francis. The list is huge. All those bodies state, robustly and clearly, that the Bill is not the mechanism to achieve those stated aims, and that is why the House should reject it.
Access to Medical Treatments (Innovation) Bill
Proceeding contribution from
Sarah Wollaston
(Conservative)
in the House of Commons on Friday, 16 October 2015.
It occurred during Debate on bills on Access to Medical Treatments (Innovation) Bill.
About this proceeding contribution
Reference
600 c577 Session
2015-16Chamber / Committee
House of Commons chamberLibrarians' tools
Timestamp
2021-11-04 13:31:30 +0000
URI
http://hansard.intranet.data.parliament.uk/Commons/2015-10-16/15101634000220
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Commons/2015-10-16/15101634000220
In Solr
https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Commons/2015-10-16/15101634000220